Skip to content
healthcare.dev
Get a free key

Emetrol Chewables

NDC 65197-204, Sodium citrate dihydrate, tablet, chewable, from WellSpring Pharmaceutical Corporation.

Product NDC
65197-204
Status
Listed
Labeler
WellSpring Pharmaceutical Corporation
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65197-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRISODIUM CITRATE DIHYDRATE230 mg/1

Pharmacologic classes

Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]

Package NDCNDC-11Package
65197-204-42651970204421 BOTTLE in 1 BOX (65197-204-42) / 42 TABLET, CHEWABLE in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 65197-204 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65197-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65197-204. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.